Literature DB >> 30073498

Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.

Jin You Kim1,2, Jin Joo Kim3, Ji Won Lee3, Nam Kyung Lee3, Geewon Lee3, Taewoo Kang4, Heesung Park4, Yo Han Son5, Robert Grimm6.   

Abstract

OBJECTIVES: To investigate the value of the whole-lesion histogram apparent diffusion coefficient (ADC) metrics for differentiating low-risk from non-low-risk ductal carcinoma in situ (DCIS).
METHODS: The authors identified 93 women with pure DCIS who had undergone preoperative MR imaging and diffusion-weighted imaging from 2013 to 2016. Histogram analysis of pixel-based ADC data of the whole tumour volume was performed by two radiologists using a software tool. The results were compared between low-risk and non-low-risk DCIS. Associations between quantitative ADC metrics and low-risk DCIS were evaluated by receiver operating characteristics (ROC) curve and logistic regression analyses.
RESULTS: In whole-lesion histogram analysis, mean ADC and 5th, 50th and 95th percentiles of ADC were significantly different between low-risk and non-low-risk DCIS (1.522, 1.207, 1.536 and 1.854 × 10-3 mm2/s versus 1.270, 0.917, 1.261 and 1.657 × 10-3 mm2/s, respectively; p = .004, p = .003, p = .004 and p = .024, respectively). ROC curve analysis for differentiating low-risk DCIS revealed that 5th percentile ADC yielded the largest area under the curve (0.786) among the metrics of whole-lesion histogram, and the optimal cut-off point was 1.078 × 10-3 mm2/s (sensitivity 80%, specificity 75.9%, p = .001). Multivariate regression analysis revealed that a high 5th percentile of ADC (> 1.078× 10-3 mm2/s; odds ratio [OR] = 10.494, p = .016), small tumour size (≤ 2 cm; OR = 12.692, p = .008) and low Ki-67 status (< 14%; OR = 10.879, p = .046) were significantly associated with low-risk DCIS.
CONCLUSIONS: Assessment with whole-lesion histogram analysis of the ADC could be helpful for identifying patients with low-risk DCIS. KEY POINTS: • Whole-lesion histogram ADC metrics could be helpful for differentiating low-risk from non-low-risk DCIS. • A high 5th percentile ADC was a significant factor associated with low-risk DCIS. • Risk stratification of DCIS is important for their management.

Entities:  

Keywords:  Breast neoplasm; Diffusion magnetic resonance imaging; Ductal carcinoma in situ; Magnetic resonance imaging; Risk

Mesh:

Year:  2018        PMID: 30073498     DOI: 10.1007/s00330-018-5666-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  34 in total

1.  Detection of ductal carcinoma in situ in women undergoing screening mammography.

Authors:  Virginia L Ernster; Rachel Ballard-Barbash; William E Barlow; Yingye Zheng; Donald L Weaver; Gary Cutter; Bonnie C Yankaskas; Robert Rosenberg; Patricia A Carney; Karla Kerlikowske; Stephen H Taplin; Nicole Urban; Berta M Geller
Journal:  J Natl Cancer Inst       Date:  2002-10-16       Impact factor: 13.506

2.  Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.

Authors:  Savannah C Partridge; Christiane D Mullins; Brenda F Kurland; Michael D Allain; Wendy B DeMartini; Peter R Eby; Constance D Lehman
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

3.  The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.

Authors:  Melinda E Sanders; Peggy A Schuyler; William D Dupont; David L Page
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

4.  Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging.

Authors:  Yong Guo; You-Quan Cai; Zu-Long Cai; Yuan-Gui Gao; Ning-Yu An; Lin Ma; Srikanth Mahankali; Jia-Hong Gao
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

5.  Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.

Authors:  Sanaz A Jansen; Gillian M Newstead; Hiroyuki Abe; Akiko Shimauchi; Robert A Schmidt; Gregory S Karczmar
Journal:  Radiology       Date:  2007-12       Impact factor: 11.105

6.  In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology.

Authors:  Yoshitsugu Matsumoto; Masahiro Kuroda; Ryohei Matsuya; Hirokazu Kato; Koichi Shibuya; Masataka Oita; Atsushi Kawabe; Hidenobu Matsuzaki; Junichi Asaumi; Jun Murakami; Kazunori Katashima; Masakazu Ashida; Takanori Sasaki; Tetsuro Sei; Susumu Kanazawa; Seiichi Mimura; Seiichiro Oono; Takuichi Kitayama; Seiji Tahara; Keiji Inamura
Journal:  Oncol Rep       Date:  2009-09       Impact factor: 3.906

Review 7.  Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

Authors:  Beth A Virnig; Todd M Tuttle; Tatyana Shamliyan; Robert L Kane
Journal:  J Natl Cancer Inst       Date:  2010-01-13       Impact factor: 13.506

8.  Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome.

Authors:  Christopher B Moeder; Jennifer M Giltnane; Malini Harigopal; Annette Molinaro; Andrew Robinson; Karen Gelmon; David Huntsman; Robert L Camp; David L Rimm
Journal:  J Clin Oncol       Date:  2007-12-01       Impact factor: 44.544

9.  Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?

Authors:  Siwa Chan; Jeon-Hor Chen; Garima Agrawal; Muqing Lin; Rita S Mehta; Philip M Carpenter; Orhan Nalcioglu; Min-Ying Su
Journal:  J Oncol       Date:  2010-09-21       Impact factor: 4.375

10.  Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion.

Authors:  C Marini; C Iacconi; M Giannelli; A Cilotti; M Moretti; C Bartolozzi
Journal:  Eur Radiol       Date:  2007-03-14       Impact factor: 7.034

View more
  9 in total

1.  Volumetric apparent diffusion coefficient histogram analysis of the testes in nonobstructive azoospermia: a noninvasive fingerprint of impaired spermatogenesis?

Authors:  Athina C Tsili; Loukas G Astrakas; Anna C Goussia; Nikolaos Sofikitis; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2022-04-29       Impact factor: 5.315

2.  Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk.

Authors:  Jin You Kim; Jin Joo Kim; Lee Hwangbo; Ji Won Lee; Nam Kyung Lee; Kyung Jin Nam; Ki Seok Choo; Taewoo Kang; Heeseung Park; Yohan Son; Robert Grimm
Journal:  Eur Radiol       Date:  2019-08-05       Impact factor: 5.315

3.  Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions.

Authors:  Alexey Surov; Hans Jonas Meyer; Andreas Wienke
Journal:  BMC Cancer       Date:  2019-10-15       Impact factor: 4.430

4.  Whole-Lesion Histogram Analysis of the Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker for Assessing the Level of Tumor-Infiltrating Lymphocytes: Value in Molecular Subtypes of Breast Cancer.

Authors:  Wen-Jie Tang; Zhe Jin; Yan-Ling Zhang; Yun-Shi Liang; Zi-Xuan Cheng; Lei-Xin Chen; Ying-Ying Liang; Xin-Hua Wei; Qing-Cong Kong; Yuan Guo; Xin-Qing Jiang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

5.  Whole-lesion apparent diffusion coefficient (ADC) histogram as a quantitative biomarker to preoperatively differentiate stage IA endometrial carcinoma from benign endometrial lesions.

Authors:  Jieying Zhang; Xiaoduo Yu; Xiaomiao Zhang; Shuang Chen; Yan Song; Lizhi Xie; Yan Chen; Han Ouyang
Journal:  BMC Med Imaging       Date:  2022-08-08       Impact factor: 2.795

Review 6.  [Diffusion-Weighted Imaging as a Stand-Alone Breast Imaging Modality].

Authors:  Hee Jung Shin; Su Hyun Lee; Woo Kyung Moon
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-01-31

7.  Utility of noncontrast MRI in the detection and risk grading of gastrointestinal stromal tumor: a comparison with contrast-enhanced CT.

Authors:  Ziling Zhou; Jingyu Lu; John N Morelli; Daoyu Hu; Zhen Li; Peng Xiao; Xuemei Hu; Yaqi Shen
Journal:  Quant Imaging Med Surg       Date:  2021-06

8.  Turbo Spin-echo Diffusion-weighted Imaging Compared with Single-shot Echo-planar Diffusion-weighted Imaging: Image Quality and Diagnostic Performance When Differentiating between Ductal Carcinoma in situ and Invasive Ductal Carcinoma.

Authors:  Naoko Mori; Shunji Mugikura; Minoru Miyashita; Yu Mori; Yui Maekawa; Tatsuo Nagasaka; Kei Takase
Journal:  Magn Reson Med Sci       Date:  2020-03-06       Impact factor: 2.471

9.  Whole Volume Apparent Diffusion Coefficient (ADC) Histogram as a Quantitative Imaging Biomarker to Differentiate Breast Lesions: Correlation with the Ki-67 Proliferation Index.

Authors:  Yuan Guo; Qing-Cong Kong; Li-Qi Li; Wen-Jie Tang; Wan-Li Zhang; Guan-Yuan Ning; Jun Xue; Qian-Wei Zhou; Ying-Ying Liang; Mei Wu; Xin-Qing Jiang
Journal:  Biomed Res Int       Date:  2021-06-24       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.